Avricore Health Statistics
Total Valuation
Avricore Health has a market cap or net worth of 4.07 million. The enterprise value is 3.14 million.
Market Cap | 4.07M |
Enterprise Value | 3.14M |
Important Dates
The last earnings date was Thursday, May 29, 2025.
Earnings Date | May 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 101.29M |
Shares Outstanding | n/a |
Shares Change (YoY) | +1.03% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 90.96M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.43 |
PB Ratio | 3.00 |
P/TBV Ratio | 3.11 |
P/FCF Ratio | 9.05 |
P/OCF Ratio | 7.15 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.25, with an EV/FCF ratio of 6.97.
EV / Earnings | -4.93 |
EV / Sales | 1.05 |
EV / EBITDA | 14.25 |
EV / EBIT | n/a |
EV / FCF | 6.97 |
Financial Position
The company has a current ratio of 7.40
Current Ratio | 7.40 |
Quick Ratio | 7.10 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.85% and return on invested capital (ROIC) is -2.00%.
Return on Equity (ROE) | -43.85% |
Return on Assets (ROA) | -1.69% |
Return on Invested Capital (ROIC) | -2.00% |
Return on Capital Employed (ROCE) | -3.43% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 1.66 |
Inventory Turnover | 357.92 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.42% in the last 52 weeks. The beta is -1.61, so Avricore Health's price volatility has been lower than the market average.
Beta (5Y) | -1.61 |
52-Week Price Change | -67.42% |
50-Day Moving Average | 0.04 |
200-Day Moving Average | 0.07 |
Relative Strength Index (RSI) | 53.12 |
Average Volume (20 Days) | 52,905 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Avricore Health had revenue of 2.85 million and -636,502 in losses. Loss per share was -0.01.
Revenue | 2.85M |
Gross Profit | 1.21M |
Operating Income | -46,541 |
Pretax Income | -636,502 |
Net Income | -636,502 |
EBITDA | 209,438 |
EBIT | -46,541 |
Loss Per Share | -0.01 |
Balance Sheet
The company has 890,322 in cash and n/a in debt, giving a net cash position of 890,322.
Cash & Cash Equivalents | 890,322 |
Total Debt | n/a |
Net Cash | 890,322 |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.36M |
Book Value Per Share | 0.01 |
Working Capital | 832,744 |
Cash Flow
In the last 12 months, operating cash flow was 569,101 and capital expenditures -119,172, giving a free cash flow of 449,929.
Operating Cash Flow | 569,101 |
Capital Expenditures | -119,172 |
Free Cash Flow | 449,929 |
FCF Per Share | n/a |
Margins
Gross margin is 42.53%, with operating and profit margins of -1.63% and -22.34%.
Gross Margin | 42.53% |
Operating Margin | -1.63% |
Pretax Margin | -22.34% |
Profit Margin | -22.34% |
EBITDA Margin | 7.35% |
EBIT Margin | -1.63% |
FCF Margin | 15.79% |
Dividends & Yields
Avricore Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.03% |
Shareholder Yield | n/a |
Earnings Yield | -15.64% |
FCF Yield | 11.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.25.
Last Split Date | Nov 21, 2016 |
Split Type | Reverse |
Split Ratio | 0.25 |
Scores
Avricore Health has an Altman Z-Score of 27.17.
Altman Z-Score | 27.17 |
Piotroski F-Score | n/a |